Cardiac Surgery at Weill Cornell Medicine|NewYork-Presbyterian offers both proven surgical modalities and new, minimally invasive approaches for the treatment of coronary artery disease, thoracic aortic aneurysm, valvular disease, arrythmias and adult congenital heart disease. Read More.
Conditions & Treatments
- Adult Congenital Heart Surgery
- Aortic Aneurysm and Dissection Repair
- Aortic Valve Repair and Replacement
- Cardiac Tumors
- Coronary Artery Bypass Graft (CABG)
- Extracorporeal Life Support (ECMO)
- Heart Surgery for Older Adults
- Heart Transplant
- Minimally Invasive Heart Surgery
- Mitral Valve Repair and Replacement
- Pediatric Cardiac Surgery
- Pericardial Diseases
- Robotic Heart Surgery
- Surgical Treatment of Atrial Fibrillation (CryoMAZE)
- Transcatheter Valve Replacement (TAVR)
- Ventricular Assist Devices (VADs)
Our Surgeons
Ronald O. Perelman Heart Institute
The Ronald O. Perelman Heart Institute is the new home for world-class heart care at Weill Cornell Medicine|NewYork-Presbyterian Hospital. The facility sets the standard for patient-focused comprehensive care for New Yorkers and patients throughout the world.
William Acquavella Heart Valve Center
The specialists at the William Acquavella Heart Valve Center at Weill Cornell Medicine|NewYork-Presbyterian are leaders in the development and evaluation of novel, less invasive techniques for repairing and replacing damaged mitral, aortic and pulmonary valves. Our team played a leading role in the clinical trials assessing the latest percutaneous valve replacement approaches, giving us more experience than most centers in these emerging new techniques.
Phone: 646-NYP-VALVE (646-697-8258)
Email: cornellheartvalve@nyp.org
In randomized clinical trials, commercial sponsorship influences how studies are designed and the results reported in ways that often benefit the study’s sponsor, Weill Cornell Medicine and NewYork-Presbyterian investigators report in a new study. The findings underscore the need to improve study design, reporting and guidelines to avoid bias in these trials, the authors say.
